Survey shows executives turning to automation, AI, and domestic production amid geopolitical and regulatory shifts TAMPA, ...

Aura Minerals Inc. (TSX: ORA) (B3: AURA33) (OTCQX: ORAAF) (“Aura” or the “Company”) is pleased to report updated Mineral ...

Chaim Lebovits; President, Chief Executive Officer; Brainstorm Cell Therapeutics Inc. Alla Patlis; Interim Chief ...

Donald Trump has announced tariffs of 10 per cent on Britain as part of a “declaration of economic independence” by the US.

The worldwide fallout of the US President Donald Trump’s tariffs could hit the European Union particularly hard, economists who spoke to RFE/RL said, sparking fears of coming inflation and an embattle ...

and CAMBRIDGE, United Kingdom, March 31, 2025 (GLOBE NEWSWIRE) -- Conduit Pharmaceuticals Inc. (Nasdaq ... or otherwise. Conduit gives no assurance that it will achieve its expectations.

The Executive Secretary, Tertiary Education Trust Fund, Sonny Echono, highlights TETFUND’s massive investments in research ...

WASHINGTON, March 31, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (NASDAQ ... to complete the Phase III clinical study of Bysanti™ for the treatment of MDD and receive results in 2026.

Biopharmaceutical company developing drugs for neurological disorders.

Healthcare & Pharmaceuticalscategory· March 14, 2025 Drugmakers agree to participate in second round of price negotiations All drug manufacturers, including Novo Nordisk and Teva Pharmaceuticals ...

Researching and developing therapeutic products for human use.